Exosens Technologies SA (EXENS.PA) is a leading provider of advanced optoelectronic solutions and image sensors for industrial, medical, scientific, and defense applications. The company develops and manufactures high-performance sensors, including CMOS image sensors, SWIR detectors, and X-ray imaging solutions; electron microscopy components such as cameras and detectors; and specialized systems for night vision, LiDAR, and hyperspectral imaging under brands like Lynred for infrared technologies and Teledyne e2v for scientific imaging. Exosens serves target markets including aerospace and defense, medical diagnostics, semiconductor inspection, and research institutions, with operations spanning Europe, North America, and Asia.
Founded in 2023 through the acquisition and rebranding of Teledyne e2v by the European consortium Wisag, which includes investment from shareholder Partech, Exosens is headquartered in Paris, France, with key facilities in Grenoble, France; Chelmsford, UK; and global sites in the United States and Asia.
In recent developments, Exosens completed its initial public offering on Euronext Paris in October 2024, raising approximately EUR 324 million to fuel expansion in AI-driven imaging and strategic growth initiatives; announced a strategic partnership with STMicroelectronics in 2025 to co-develop next-generation SPAD-based LiDAR sensors for automotive and robotics; and launched the new Emerald SWIR sensor platform in mid-2025, enhancing compact hyperspectral imaging for industrial sorting and defense reconnaissance.